Dimension Therapeutics, Inc. Earnings Per Share, Basic and Diluted
Dimension Therapeutics, Inc. reported Earnings Per Share, Basic and Diluted of -$0.68 per share for the 3-month period ending 2017-09-30, per its 10-Q filed 2017-11-06.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2017-11-06
- Dimension Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2017-09-30 was -$0.68.
- Dimension Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2017-06-30 was -$0.49.
- Dimension Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2017-03-31 was -$0.54.
- Dimension Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2016-12-31 was -$0.52.
- Dimension Therapeutics, Inc. earnings per share, basic and diluted for fiscal 2016 was -$1.97.
- Dimension Therapeutics, Inc. earnings per share, basic and diluted for fiscal 2015 was -$4.41.
- Dimension Therapeutics, Inc. earnings per share, basic and diluted for fiscal 2014 was -$3.61.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2017-09-30 | -$0.68 10-Q · filed 2017-11-06 | -$1.71 10-Q · filed 2017-11-06 | ||
| 2017-06-30 | -$0.49 10-Q · filed 2017-08-08 | -$1.03 10-Q · filed 2017-08-08 | ||
| 2017-03-31 | -$0.54 10-Q · filed 2017-05-10 | |||
| 2016-12-31 | -$0.52 10-K · filed 2017-03-09 | -$1.10 derived: net income ÷ weighted average shares · filed 2017-11-06 | -$1.58 derived: net income ÷ weighted average shares · filed 2017-11-06 | -$1.97 10-K · filed 2017-03-09 |
| 2016-09-30 | -$0.58 10-Q · filed 2017-11-06 | -$1.06 derived: net income ÷ weighted average shares · filed 2017-11-06 | -$1.44 10-Q · filed 2017-11-06 | -$1.90 derived: net income ÷ weighted average shares · filed 2017-11-06 |
| 2016-06-30 | -$0.49 10-Q · filed 2017-08-08 | -$0.87 10-Q · filed 2017-08-08 | -$1.32 derived: net income ÷ weighted average shares · filed 2017-08-08 | -$2.24 derived: net income ÷ weighted average shares · filed 2017-08-08 |
| 2016-03-31 | -$0.38 10-Q · filed 2017-05-10 | -$0.83 derived: net income ÷ weighted average shares · filed 2017-05-10 | -$1.80 derived: net income ÷ weighted average shares · filed 2017-05-10 | -$2.98 derived: net income ÷ weighted average shares · filed 2017-05-10 |
| 2015-12-31 | -$0.45 10-K · filed 2017-03-09 | -$1.65 derived: net income ÷ weighted average shares · filed 2017-03-09 | -$3.20 derived: net income ÷ weighted average shares · filed 2017-03-09 | -$4.41 10-K · filed 2017-03-09 |
| 2015-09-30 | -$2.73 10-K · filed 2017-03-09 | -$5.30 derived: net income ÷ weighted average shares · filed 2017-03-09 | -$6.71 10-Q · filed 2016-11-10 | -$8.00 derived: net income ÷ weighted average shares · filed 2017-03-09 |
| 2015-06-30 | -$2.57 10-K · filed 2017-03-09 | -$3.98 10-Q · filed 2016-08-11 | -$5.25 derived: net income ÷ weighted average shares · filed 2017-03-09 | -$6.00 derived: net income ÷ weighted average shares · filed 2017-03-09 |
| 2015-03-31 | -$1.40 10-K · filed 2017-03-09 | -$2.66 derived: net income ÷ weighted average shares · filed 2017-03-09 | -$3.38 derived: net income ÷ weighted average shares · filed 2017-03-09 | -$4.48 derived: net income ÷ weighted average shares · filed 2017-03-09 |
| 2014-12-31 | -$1.25 10-K · filed 2016-03-24 | -$1.96 derived: net income ÷ weighted average shares · filed 2016-03-24 | -$3.06 derived: net income ÷ weighted average shares · filed 2016-03-24 | -$3.61 10-K · filed 2017-03-09 |
| 2014-09-30 | -$0.70 10-K · filed 2016-03-24 | -$1.79 derived: net income ÷ weighted average shares · filed 2016-03-24 | -$2.35 10-Q · filed 2015-12-04 | |
| 2014-06-30 | -$1.10 10-K · filed 2016-03-24 | -$1.65 derived: net income ÷ weighted average shares · filed 2016-03-24 | ||
| 2014-03-31 | -$0.55 10-K · filed 2016-03-24 | |||
| 2013-12-31 | -$2.71 10-K · filed 2016-03-24 |